NBP
NovaBridge Biosciences
1.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | |
| – | – | – | – | 52.7% | – | 0.0% | – | – | |
| 102.6% | 100.0% | 100.0% | 100.0% | 47.3% | – | 100.0% | – | – | |
| 2,370.8% | 792.2% | 2,801.4% | 63.8% | 216.2% | – | 2,549.4% | – | – | |
| 225.8% | 123.4% | 2,181.8% | 26.1% | 1,022.4% | – | 1,424.7% | – | – | |
| 2,596.6% | 915.6% | 4,983.2% | 89.9% | 2,400.3% | – | 11,495.1% | – | – | |
| -2,431.2% | -847.4% | -4,883.2% | 10.1% | -2,353.1% | – | -11,395.1% | – | – | |
| 7.7% | 3.2% | 1.4% | 0.0% | 0.0% | – | 2.3% | – | – | |
| -2,580.8% | -774.9% | -4,839.8% | 31.3% | -2,649.3% | – | -32,674.0% | – | – | |
| – | 3.2% | – | 0.8% | -0.6% | – | -28,064.6% | – | – | |
| -2,647.4% | -749.0% | -4,826.8% | 30.5% | -2,648.7% | – | -32,674.0% | – | – | |
| -2,479.5% | -803.1% | -657.5% | 10.9% | -2,337.4% | – | -7,674.2% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.